» Articles » PMID: 33147555

Microbiome in Cancer Progression and Therapy

Overview
Specialty Microbiology
Date 2020 Nov 4
PMID 33147555
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

A myriad of microbes living together with the host constitute microbiota, which possesses very diverse functions in regulation of host physiology. Recently, it has been unequivocally demonstrated that microbiota regulates cancer initiation, progression and responses to therapy. Here we review known pro-tumorigenic and anti-tumorigenic function of microbiota and mechanisms how microbes can regulate cancer cells and immune and stromal cells within the tumor microenvironment.

Citing Articles

Metagenomic and Transcriptomic Analysis Reveals Crosstalk Between Intratumor Mycobiome and Hosts in Early-Stage Nonsmoking Lung Adenocarcinoma Patients.

Sun Y, Gan Z, Liu S, Zhang S, Zhong W, Liu J Thorac Cancer. 2025; 16(2):e15527.

PMID: 39853685 PMC: 11756924. DOI: 10.1111/1759-7714.15527.


The emerging tumor microbe microenvironment: From delineation to multidisciplinary approach-based interventions.

Fu Y, Li J, Cai W, Huang Y, Liu X, Ma Z Acta Pharm Sin B. 2024; 14(4):1560-1591.

PMID: 38572104 PMC: 10985043. DOI: 10.1016/j.apsb.2023.11.018.


Gut microbiota and its therapeutic implications in tumor microenvironment interactions.

Feng P, Xue X, Bukhari I, Qiu C, Li Y, Zheng P Front Microbiol. 2024; 15:1287077.

PMID: 38322318 PMC: 10844568. DOI: 10.3389/fmicb.2024.1287077.


Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications.

Zhao L, Mei J, Yu G, Lei L, Zhang W, Liu K Signal Transduct Target Ther. 2023; 8(1):201.

PMID: 37179402 PMC: 10183032. DOI: 10.1038/s41392-023-01406-7.


Gut Microbiome Composition and Its Metabolites Are a Key Regulating Factor for Malignant Transformation, Metastasis and Antitumor Immunity.

Lozenov S, Krastev B, Nikolaev G, Peshevska-Sekulovska M, Peruhova M, Velikova T Int J Mol Sci. 2023; 24(6).

PMID: 36983053 PMC: 10054493. DOI: 10.3390/ijms24065978.


References
1.
Chittim C, Martinez Del Campo A, Balskus E . Gut bacterial phospholipase Ds support disease-associated metabolism by generating choline. Nat Microbiol. 2018; 4(1):155-163. DOI: 10.1038/s41564-018-0294-4. View

2.
Litvak Y, Mon K, Nguyen H, Chanthavixay G, Liou M, Velazquez E . Commensal Enterobacteriaceae Protect against Salmonella Colonization through Oxygen Competition. Cell Host Microbe. 2019; 25(1):128-139.e5. DOI: 10.1016/j.chom.2018.12.003. View

3.
Tilg H, Adolph T, Gerner R, Moschen A . The Intestinal Microbiota in Colorectal Cancer. Cancer Cell. 2018; 33(6):954-964. DOI: 10.1016/j.ccell.2018.03.004. View

4.
Merlos-Suarez A, Barriga F, Jung P, Iglesias M, Cespedes M, Rossell D . The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell. 2011; 8(5):511-24. DOI: 10.1016/j.stem.2011.02.020. View

5.
Chung L, Thiele Orberg E, Geis A, Chan J, Fu K, DeStefano Shields C . Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells. Cell Host Microbe. 2018; 23(3):421. PMC: 6469393. DOI: 10.1016/j.chom.2018.02.004. View